O'Neil Global Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,336
Closed -$387K 55
2023
Q3
$387K Sell
7,336
-6,126
-46% -$321K 0.35% 40
2023
Q2
$728K Buy
13,462
+8,462
+169% +$442K 0.15% 44
2023
Q1
$250K Buy
+5,000
New +$236K 0.13% 60
2021
Q4
Sell
-21,000
Closed -$911K 56
2021
Q3
$911K Buy
21,000
+5,000
+31% +$221K 0.7% 18
2021
Q2
$684K Buy
+16,000
New +$673K 0.21% 50

Other funds holding BSX

O'Neil Global Advisors's BSX Position: Q4 2023 in Review

O'Neil Global Advisors sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 7,336 shares — an estimated $387K sold.

O'Neil Global Advisors first reported a position in BSX in Q2 2021 and held it in 5 quarters. The position peaked at $911K in Q3 2021. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • O'Neil Global Advisors reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
  • O'Neil Global Advisors sold 7,336 Boston Scientific shares in Q4 2023, an estimated $387K.
  • O'Neil Global Advisors first reported a position in Boston Scientific in Q2 2021 and held it in 5 quarters.
  • O'Neil Global Advisors's Boston Scientific position peaked at $911K in Q3 2021.
  • 1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on O'Neil Global Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.